THE NEXT DIMENSION COMPANY

Since its inception in 1998, the company has become a significant player in the pharmaceutical market. Through flourishing business relations with demanding international clients, IntelliPharmaCeutics continues to exceed expectations.

We believe that we are at the forefront of the design and the development of controlled release drugs. The core drug delivery technology employed by IntelliPharmaCeutics is its patented HYPERMATRIX™ technology, which is a sophisticated and robust drug delivery platform. Utilizing this technology, our scientists are able to provide life cycle management or new chemical entity delivery system solutions for a wide range of small drug molecules. By recognizing that the key to remaining at the forefront of technological know-how requires housing the best and brightest corporate and scientific minds, IntelliPharmaCeutics expects tocontinue to grow in the international pharmaceutical market.  

Our company success hinges on the simplicity of our business model. Our goal is to produce the worlds’ most sophisticated controlled release drug delivery technology surpassing the industry’s most competitive timeframes.